Prof David Baldwin, Outcome Prediction and New Treatment Paradigms (WP8)

Prof David Baldwin works as a consultant respiratory physician sub-specialising in lung cancer and mesothelioma and interventional procedures. He is an Honorary Professor in the School of Medicine at the University of Nottingham. He is Chair of the UK Clinical Expert Group for Lung Cancer and Chair of the Screening Prevention and Early Diagnosis Group for the National Cancer Research Institute. He has obtained research grants from a variety of charities and NIHR to a total value of over £30M as an applicant and co-applicant.

His primary research interests are in CT screening and lung cancer epidemiology. He is leading the novel recruitment work package in the 4-in-the-Lung-Run project. He was a lead respiratory physician on the UK CT lung cancer screening trial (UKLS). He has published over 220 papers, including three influential guidelines.  He has held the positions of Honorary Secretary of the British Thoracic Society, Clinical Lead on the NICE Lung Cancer Guideline Development Group, Chair of the Quality Standards Group on Lung Cancer and Clinical Director of the East Midlands Cancer Alliance.

He enjoys time with his family and is a keen windsurfer and advanced instructor.

Prof Baldwin leads on Work Package 8 Outcome Prediction and New Treatment Paradigms and on Work Package 9 Quality Assurance: Radiologist Training and Monitoring.